POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
TVmed - wiedza medyczna dla profesjonalistów
Jak leczyć pacjenta z nowo rozpoznaną amyloidozą łańcuchów lekkich pośredniego ryzyka? Rola doksycykliny w terapii amylo
Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
IHC-plus™ DDB1 Monoclonal Antibody Mouse anti-Human | LSBio
CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma - Publication - Bridge of Knowledge
Dzisiaj rusza ogólnopolska kampania edukacyjna „Choroby Krwi” | Hematoonkologia.pl
Frontiers | A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia
Rebecca Silbermann M.D., M.M.S. | OHSU People | OHSU
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos | Journal of Medicinal Chemistry
Diagnostics | Free Full-Text | Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
Biomedicines | Free Full-Text | Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors - ScienceDirect
PDF) The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
Frontiers | Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation
Klinika Hematologii - Instytut Hematologii i Transfuzjologii - Portal Pacjenta
Diagnostics | Free Full-Text | Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
Diagnostics | Free Full-Text | Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results f
Rebecca Silbermann M.D., M.M.S. | OHSU People | OHSU
Rola daratumumabu w leczeniu chorych na nawrotowego i opornego szpiczaka plazmocytowego
EHA Library - The official digital education library of European Hematology Association (EHA)
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma | Journal of Medicinal Chemistry
Bayesian combination of mechanistic modeling and machine learning (BaM3): improving personalized tumor growth predictions
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model | SpringerLink
